Ace Therapeutics is an expert in the field of hepatitis virus model construction. We aim to promote your research by providing the most scientific and professional experimental models.

More than 71 million people worldwide are chronically infected with the hepatitis C virus, which leads to a significantly increased risk of liver fibrosis, decompensated cirrhosis, and hepatocellular carcinoma. This situation makes the study of hepatitis C virus infection more urgent. We aim to facilitate the progress of this research by providing high-quality models of hepatitis C virus infection. Source from: Hepatitis C Virus Infection Model Customization Services